Chrysin Ameliorates Malfunction of Retinoid Visual Cycle through Blocking Activation of AGE-RAGE-ER Stress in Glucose-Stimulated Retinal Pigment Epithelial Cells and Diabetic Eyes

Nutrients. 2018 Aug 8;10(8):1046. doi: 10.3390/nu10081046.

Abstract

Diabetes-associated visual cycle impairment has been implicated in diabetic retinopathy, and chronic hyperglycemia causes detrimental effects on visual function. Chrysin, a naturally occurring flavonoid found in various herbs, has anti-inflammatory, antioxidant, and neuroprotective properties. The goal of the current study was to identify the retinoprotective role of chrysin in maintaining robust retinoid visual cycle-related components. The in vitro study employed human retinal pigment epithelial (RPE) cells exposed to 33 mM of glucose or advanced glycation end products (AGEs) in the presence of 1⁻20 μM chrysin for three days. In the in vivo study, 10 mg/kg of chrysin was orally administrated to db/db mice. Treating chrysin reversed the glucose-induced production of vascular endothelial growth factor, insulin-like growth factor-1, and pigment epithelium-derived factor (PEDF) in RPE cells. The outer nuclear layer thickness of chrysin-exposed retina was enhanced. The oral gavage of chrysin augmented the levels of the visual cycle enzymes of RPE65, lecithin retinol acyltransferase (LRAT), retinol dehydrogenase 5 (RDH5), and rhodopsin diminished in db/db mouse retina. The diabetic tissue levels of the retinoid binding proteins and the receptor of the cellular retinol-binding protein, cellular retinaldehyde-binding protein-1, interphotoreceptor retinoid-binding protein and stimulated by retinoic acid 6 were restored to those of normal mouse retina. The presence of chrysin demoted AGE secretion and AGE receptor (RAGE) induction in glucose-exposed RPE cells and diabetic eyes. Chrysin inhibited the reduction of PEDF, RPE 65, LRAT, and RDH5 in 100 μg/mL of AGE-bovine serum albumin-exposed RPE cells. The treatment of RPE cells with chrysin reduced the activation of endoplasmic reticulum (ER) stress. Chrysin inhibited the impairment of the retinoid visual cycle through blocking ER stress via the AGE-RAGE activation in glucose-stimulated RPE cells and diabetic eyes. This is the first study demonstrating the protective effects of chrysin on the diabetes-associated malfunctioned visual cycle.

Keywords: advanced glycation end products; chyrsin; diabetic retinopathy; endoplasmic reticulum; retinal pigment epithelium; visual cycle.

MeSH terms

  • Animals
  • Cell Line
  • Diabetic Retinopathy / metabolism
  • Diabetic Retinopathy / pathology
  • Diabetic Retinopathy / physiopathology
  • Diabetic Retinopathy / prevention & control*
  • Disease Models, Animal
  • Endoplasmic Reticulum Stress / drug effects*
  • Epithelial Cells / drug effects*
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology
  • Eye Proteins / metabolism
  • Flavonoids / pharmacology*
  • Glucose / toxicity*
  • Glycation End Products, Advanced / toxicity*
  • Humans
  • Male
  • Mice, Inbred C57BL
  • Protective Agents / pharmacology*
  • Receptor for Advanced Glycation End Products / metabolism*
  • Retinal Pigment Epithelium / drug effects*
  • Retinal Pigment Epithelium / metabolism
  • Retinal Pigment Epithelium / pathology
  • Retinal Pigment Epithelium / physiopathology
  • Serum Albumin, Bovine / toxicity*
  • Signal Transduction / drug effects
  • Vision, Ocular / drug effects*

Substances

  • AGER protein, human
  • Ager protein, mouse
  • Eye Proteins
  • Flavonoids
  • Glycation End Products, Advanced
  • Protective Agents
  • Receptor for Advanced Glycation End Products
  • advanced glycation end products-bovine serum albumin
  • Serum Albumin, Bovine
  • chrysin
  • Glucose